3,5-dihydroxyphenylglycine has been researched along with pyrrolidine-2,4-dicarboxylic acid in 1 studies
| Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) | Studies (pyrrolidine-2,4-dicarboxylic acid) | Trials (pyrrolidine-2,4-dicarboxylic acid) | Recent Studies (post-2010) (pyrrolidine-2,4-dicarboxylic acid) |
|---|---|---|---|---|---|
| 301 | 1 | 61 | 190 | 0 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrero, I; Manahan-Vaughan, D; Reymann, KG; Sánchez-Prieto, J | 1 |
1 other study(ies) available for 3,5-dihydroxyphenylglycine and pyrrolidine-2,4-dicarboxylic acid
| Article | Year |
|---|---|
Presynaptic group 1 metabotropic glutamate receptors may contribute to the expression of long-term potentiation in the hippocampal CA1 region.
Topics: Animals; Azetidinecarboxylic Acid; Calcium; Cycloleucine; Dicarboxylic Acids; Diglycerides; Electric Stimulation; Electroencephalography; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Glycine; Hippocampus; Long-Term Potentiation; Male; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Presynaptic Terminals; Pyrrolidines; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Resorcinols; Synaptosomes | 1999 |